Please update your browser.

For the best experience, we recommend that you use the latest version of Chrome, Internet Explorer, or Firefox.

Terry invests in venture and growth-oriented companies with a focus on the healthcare space.

Before joining the firm, he was with Trinity Ventures, Ltd. He spent five years as a management consultant, including experience with the Boston Consulting Group, an international strategy consulting firm. He also has experience as a founder and executive in two successful entrepreneurial companies.

Terry is a member of Adams Street’s Growth Equity Investment Committee.

Current Investments

Aptinyx, Atox Bio, Corvus, Fusion Pharmaceuticals, Icosavax, Orbus, Outpost Medicine, Partner Therapeutics, Qpex Biopharma, and Millendo

Past Investments

Heartport, Jazz Pharmaceuticals, Naurex Pharmaceuticals, NxStage Medical, Pharmacyclics, Rempex Pharmaceuticals, Revivant, Spinal Dynamics, and Vivant Medical, CombiChem, INC Research, Incline Therapeutics, and Proteus Digital Health

Learn more about Adams Street Partners